Risankizumab (anti-IL-23)
Product Specifications
CAS Number
1612838-76-2
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Risankizumab targets the p19 subunit of IL-23. Risankizumab is indicated for the treatment of psoriasis and is safe and effective in maintaining remission in active Crohn's disease.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1133629 Inquire
Recombinant Saccharomyces cerevisiae Altered inheritance of mitochondria protein 44 (AIM44), partial
Sign In for Pricing
View Details